improve their targeting and increase specificity. However, genetic modification of NK cells has been challenging due to the high expression of innate sensing mechanisms for viral nucleic acids. Recently, we described an efficient vector-free method using Cas9/ribonucleoprotein complexes for gene deletion in NK cells. Here, we combined this approach with single-stranded (ss) or self-complementary (sc)
Introduction
Gene modification of NK cells using viral or non-viral vectors has been challenging due to robust foreign DNA-and RNA-sensing mechanisms, and hence limits the efficiency of gene delivery methods into NK cells. To overcome this limitation, we have recently developed a new method to electroporate Cas9/ribonucleoprotein complexes (Cas9/RNP) directly into human primary NK cells. This method introduces a double-strand break (DSB) in the genome of NK cells, which results in successful gene knockout and enhanced antitumor activity 1 . Cas9 protein is preferable to mRNA delivery due to its fast action and clearance 2 . After this initial success in gene silencing, we thought to further develop the method for gene insertion. Following the action of Cas9 of introducing a DSB, two independent pathways may be utilized to repair the damage, known as homologous recombination (HR) and homology-independent repair. In the presence of a DNA template encoding a gene of interest, the exogenous gene can be integrated into the Cas9targeting site using either repair mechanisms 3 . There are several ways to provide such a DNA template, including viral and non-viral methods. In non-viral approaches, the single-stranded or double-stranded DNA template is typically electroporated along with Cas9/RNP 4 . For viral gene delivery, adeno-associated viruses (AAV) were used safely in clinical trials and are effective as vectors for sensitive primary immune cells,
including T-cells 5 . Transcripts that are delivered via AAV vectors can be packaged as a linear single-stranded (ss) DNA with a length of approximately 4.7 kb (ssAAV) or linear self-complementary (sc) DNA (scAAV). scAAV contains a mutated ITR which helps to bypass rate-limiting steps of second strand generation for converting ssDNA into double-stranded (ds)DNA 6 . However, as a consequence, the scAAV has only half the packaging capacity compared to ssAAV and hence is not suitable for larger transgenes 6 . Therefore, we designed and tested both ssAAV and scAAV for DNA template delivery into NK cells.
Stable gene integration through HR machinery depends on providing the transgenes with optimal homology arms for the flanking region of the DSB 7-10 . To find the most optimal length of homology arms and optimize packaging capacity of a transgene into ssAAV and scAAV, we designed 30bp, 300bp, 500bp and 800-1000 bps of HAs for the right and left side of Cas9-targeting site. Since designing homology arms is a timeconsuming procedure and requires multiple optimizations, we also investigated the CRISPaint approach, a homology-independent method for gene insertion or tagging. In this method, the same Cas9 targeting site, including crRNA and PAM sequences, is provided in the DNA template encoding the gene of interest. Upon introduction of the Cas9 complex, both template and genomic DNA will be cut simultaneously. As a result, the CRISPaint template will be presented as a linearized double-stranded DNA which can be integrated through non-homology repair machinery 4, 11 . With both methods we successfully generated highly efficient and stable transgene-modified NK cells using mCherry as a proof of concept.
Methods and Results

Human NK Cell Purification and Expansion
NK cells were purified as previously described 1 . Briefly, NK cells were isolated from PBMC using RosetteSep™ Human NK Cell Enrichment Cocktail (Figure 1 ). Purified NK cells were phenotyped using flow cytometry as >90% CD3-negative/CD56-positive population ( Figure 2 ). These cells were stimulated with irradiated mbIL21-expressing K562 feeder cells at a ratio of 2:1 (feeder:NK) at the day of purification ( Figure 1) 12 . The stimulated cells were cultured for 7 days in the serum-free AIM-V/ICSR expansion medium containing 100 IU/mL of IL-2.
Targeting Genomic safe harbors for gene insertion
Genomic safe harbors (GSHs) are sites in the genome which can be modified with no change in the normal function of the host cell and allow adequate expression of the transgene. For our proof of concept study for gene insertion in NK cells, we chose the adeno-associated virus site 1 (AAVS1), which is one of the GSHs and an exemplary locus within the phosphatase 1 regulatory subunit 12C (PPP1R12C) gene. This locus has been successfully used for directed gene insertion into several cell types 3, 13 . First, we evaluated the chromatin accessibility of AAVS1 in naïve and expanded NK cells by ATAC-seq assay and showed no difference between the naïve and IL-21 expanded cells ( Figure 3 ). AAVS1 was targeted using one gRNA (crRNA: Electroporation Enhancer) were added to the cell suspension. The total volume of 26ul of CRISPR reaction was transferred into 4D-Nucleofector TM 16-well Strip and electroporated using program EN-138. After electroporation, the cells were transferred into 2ml of serum-free media containing 100IU of IL-2 in a 12 well plate ( Figure 4 ) and incubated at 37 degrees 5% CO2 pressure.
After 48 hours, NK cell DNA was isolated for detection of Insertions deletions (Indels) in CRISPR edited NK cells. The region flanking the Cas9 targeting site was PCR amplified and the amplicons were Sanger sequenced. Inference of CRISPR Edits (ICE) was used to analyze the frequency of Indels ( Figure 5 ) 14 . The ICE results showed that more than 85% of CRISPR modified NK cells had at least one indel at the AAVS1 Cas9-targeting site. To ensure that genome modifications at this locus did not interfere with the ability to target cancer cells, we studied cytotoxicity of AAVS1-KO NK cells against Kasumi, an AML cancer cell line. Using a Calcein AM assay, we observed no difference between wild type and CRISPR modified NK cells 1 in their killing ability ( Figure 6 ).
Testing of various Adeno-Associated Viral Vector serotypes for DNA template delivery.
To determine the best serotype of AAV for transduction of primary NK cells and to provide the highest number of DNA template encoding gene of interest into NK cells, we transduced the cells with several serotypes of AAVs including AAV4, AAV6, AAV8 and AAV9 encoding GFP at a multiplicity of infection (MOI) of 300K. We saw that NK cells transduced with AAV6 had the highest expression level of GFP detected by flow cytometry. Importantly, the AAV6 viral genome could be detected up to 48 hours posttransduction by qPCR analysis, which is a critical time for the endonuclease function of Cas9 protein ( Figure   7 ).
Designing HR and CRISPaint gene delivery contructs
After successful proof of concept that the AAVS1 locus can be modified in NK cells without altering their ability to target cancer cells, we evaluated AAV mediated delivery of the mCherry transgene for gene insertion at AAVS1. For HR-directed gene insertion, DNA-encoding mCherry with homology arms (HA) to the flanking region of Cas9-targeting site were cloned into the backbone of single-stranded or selfcomplementary AAV vector 15 . We designed 30bp, 300bp, 500bp and 1000bp of HA for the right and 30bp, 300bp, 500bp and 800bp for the left HA ( Figure 8 ). For the CRISPaint DNA templates, we incorporated single (PAMg) or double (PAMgPAMg) Cas9-targeting sequences around the mCherry transgene but within the ITRs. Therefore, Cas9 could simultaneously cut gDNA and the CRISPaint DNA template, enabling integration at the genomic DSB ( Figure 9 ). To ensure the accuracy of the designed HR and CRISPaint DNA templates before packaging the transgenes into AAV6, we co-electroporated the circular DNA encoding mCherry into HEK293 cells with Cas9/RNP targeting AAVS1. The results showed that both HR and CRISPaint DNAs were successfully integrated at the genomic DSB and mCherry was efficiently expressed ( Figure 10 ). The production of both single-stranded and self-complementary AAV6 viral particles was done as previously described 15 .
Studying the NHEJ and HR pathways in the primary NK cells to determine optimal pathway for genome editing CRISPaint and HR are regulated by enzymatic reactions. CRISPaint is a LIG4-dependent process, while other proteins such as BRCA1 and BRCA2 regulate HR 11 . Therefore, we analyzed expression levels of these genes in NK cells to evaluate which repair pathway would likely be more efficient in this cell type. RNAseq analysis showed that the expanded NK cells have higher expression of BRCA1 and BRCA2 in comparison to naïve NK cells and there is no decrease in LIG4 level in these cells (Figure 11 ), providing potential optimal conditions for either HR or NHEJ-directed gene insertion through CRISPaint.
Combining Cas9/RNP and AAV6 to generate mCherry NK cells
A media change and resuspension at 5 x 10 5 cells per ml was performed on day 6 of NK cell expansion one day prior to experimental manipulation. The NK cells were then electroporated with Cas9/RNP targeting AAVS1 on day 7 as described above. Thirty minutes after electroporation, live cells were collected and resuspended at 1 x 10 6 cells per ml in media containing 100IU IL2 in a 24 well plate. For each transduction condition with ssAAV6 or scAAV6 to deliver HR or CRISPaint DNA encoding mCherry, we transduced 300K electroporated cells with 300K MOI or 150K MOI. Alternatively, to test the transduction efficiency of higher MOI of AAV6, we transduced 150,000 cells with 500K MOI of ssAAV6 delivering HR 800bp and scAAV6 delivering CRISPaint PAMgPAMg (Figure 12 ). Negative controls included NK cells that were not electroporated, were electroporated with Cas9/RNP but not AAV transduced, or were transduced with 300K MOI of AAV6 without electroporation of Cas9/RNP. The day after electroporation and transduction, we added 150ul of fresh media containing 100IU of IL2 to each well without changing the old media. The cells were kept in culture for 48 hours after electroporation and were then restimulated with K562 feeder cells at a ratio of 2:1 and kept in total volume of 1ml in 24 well plate.
Flow cytometry of CRISPR modified human NK cells shows successful integration of the mCherry gene
Two days after electroporation and transduction and before expansion, we performed flow cytometry to assess mCherry expression and viability (GhostRed 780 dye). As an overall, NK cells transduced with AAV6 delivering HR vectors had higher knock-in efficiency than CRISPaint. Furthermore, scAAV6 showed significantly better gene insertion. We did not observe mCherry expression in control NK cells.
Almost 20% of NK cells in the experimental conditions in which HR vectors were used to transduce cells with the ssAAV6 delivering DNA-encoding mCherry with 800bp of HA, were mCherry positive. For NK cells which were transduced with 300K MOI of scAAV6 delivering CRISPaint PAMg or 300K MOI and 500K MOI of PAMgPAMg we found up to 8% of mCherry positive cells. Importantly, the percentage of mCherry positive cells was significantly higher in the cells that were transduced with the scAAV6 HR vectors containing the shorter homology arms. These conditions included transduction at 300K MOI or 150K MOI of HR scAAV6 vectors with 30bp (19-20%), 300bp (80-85%), 500bp (75-85%), and 800bp (80-89%). For the cells with lower transduction efficiency (ssAAV6-HR-800bp, scAAV6-CRISPaint PAMgPAMg), we enriched the mCherry positive population to 85% by FACS sorting and continued expanding them for up to 20 days using irradiated mbIL21-expressing K562 feeder cells with no changes in the percentages of mCherry positive NK cells ( figure 13-15 ). We repeated the flow analysis for the expanded mCherry positive NK cells up to 20 days post transduction and saw no significant changes in percentages of mCherry in the cells generated by a combination of Cas9/RNP and ssAAV6 or scAAV6. Although, we saw lower efficiency of gene integration using CRISPaint compared to HR-directed gene insertion, this method is still very attractive because it allows researchers to integrate genes of interest into a user-defined locus with no need for designing homology arms. Moreover, we saw better expansion in NK cells transduced with CRISPaint vectors (data not shown).
Combining Cas9/RNP with non-viral gene delivery causes cell death in primary human NK cells
In order to minimize the time and cost of virus production, non-viral gene integration has been used in T cells 17 . We also tested this approach in NK cells by electroporating Cas9/RNP targeting AAVS1 with naked chemically-synthesized DNA encoding mCherry. The transgenes were generated in 2 forms, one as Megamer® Single-Stranded DNA Fragments from IDT with 80bp homology arms for the region flanking the Cas9-targeting site, and another with the same HR and CRISPaint DNAs that was cloned into the AAV backbone but were not packaged in any AAV capsids. Expanded NK cells were electroporated with Cas9/RNP targeting AAVS1 and 1 or 2ug of DNAs encoding mCherry in a total volume of 26ul. After 2 days, the cells with Megamer® were 100% dead, and only 10% of the cells which were electroporated with the HR and CRISPaint DNA had survived. We were able to further expand these cells, but less than 1% of the resulting cells were mCherry positive although the DNA was integrated at the site of DSB (data not shown). This indicates that AAV mediated NK cell modification is better tolerated and more efficient compared to naked DNA delivery.
Discussion
Gene modification in primary human NK cells has always been challenging, here we report the first successful highly efficient site-directed gene integration into human primary NK cells using a combination of electroporation of Cas9/RNP and single stranded or self-complementary AAV6 gene delivery through can be used for gene insertion into the AAVS1 locus in NK cells, but that the optimal length is at 300bp.
Additionally, we demonstrate that scAAV has significantly higher knock-in efficiency when combined with Cas9/RNP compared to ssAAV. We show that AAV6 is the best serotype for gene insertion into the genome of NK cells when it is combined with Cas9/RNP at 150K, 300K and 500K MOI, showing proof of concept for integrating genes into a defined locus in human primary NK cells. Our results also showed that the genemodified NK cells could be subsequently expanded using irradiated feeders, enabling production of large numbers of gene-modified NK cells at clinical scale. to produce quantitative analysis of CRISPR editing. Using this method, we showed that more than 85% of NK cells were successfully targeted at AAVS1 locus. homology arm lengths of 300bp for the flanking region of the Cas9-targeting site using scAAV6 results in highly efficient gene insertion in primary NK cells. larger HA including 500bp and 800-1000bp for smaller transgenes also can be utilized for gene insertion into NK cells. We also show that for the large transgenes 30bp of HA also can be used for gene insertion. Additionally, we demonstrate that CRISPaint is applicable approach for gene insertion into human primary NK cells. 
